Hearing: Hybrid Hearing on “Examining Emergent BioSolutions’ Failure to Protect Public Health and Public Funds”

Select Subcommittee on the Coronavirus Crisis

Wednesday, May 19, 2021 (10:30 AM)

Select one
Washington, D.C.

Witnesses

Mr. Robert G. Kramer
President and Chief Executive Officer, Emergent BioSolutions, Inc.

Added 05/18/2021 at 01:38 PM
  • Testimony [PDF] Added 05/19/2021 at 05:43 PM

Mr. Faud El-Hibri
Executive Chairman of the Board of Directors, Emergent BioSolutions, Inc.

Added 05/18/2021 at 01:38 PM
  • Testimony [PDF] Added 05/19/2021 at 05:43 PM

Support Documents

  • Notice [PDF]
  • Memo [PDF] Added 05/14/2021 at 05:49 PM
  • Ranking Member Scalise UC - Article Regarding the President’s Plan on Intellectual Property in China [PDF] Added 06/17/2021 at 12:19 PM

Hearing Record

  • Attendance [PDF] Added 05/20/2021 at 10:26 AM
  • Questions for the Record Responses from Mr. Kramer [PDF] Added 06/17/2021 at 01:06 PM
  • Questions for the Record Responses from Mr. El-Hibri [PDF] Added 06/17/2021 at 01:06 PM
  • Transcript [PDF] Added 07/23/2021 at 05:23 PM

First Published: May 11, 2021 at 05:41 PM
Last Updated: July 23, 2021 at 05:23 PM

Hybrid Hearing on “Examining Emergent BioSolutions’ Failure to Protect Public Health and Public Funds”

Select Subcommittee on the Coronavirus Crisis

Error Encountered
There was an error retrieving data for this meeting. The following error was returned: [Object reference not set to an instance of an object.]. Please retry your request again or try again later.

Meeting ID: 112641
Publish ID: HHRG112641
Published on: 5/11/2021 5:41:52 PM
Exception Category: General
1/23/2025 10:08:00 AM